comparemela.com

Eelco Ebbers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities

Symeres, a leading global drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), today announces the acquisition of Oncolines, a Netherlands-based CRO that provides early biology services and cell-line profiling assays. Oncolines is Symeres’ third .

Symeres Acquires Exemplify BioPharma

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Symeres acquires Exemplify BioPharma, further strengthening its strategic foothold in the US

NIJMEGEN, Netherlands, Oct. 25, 2022 /PRNewswire/ Symeres, a leading global drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.